News
Notably, Pfizer's Comirnaty COVID vaccine is still approved or authorized for people 6 months of age and older without any restrictions based on risk factors for COVID — at least for now. But the FDA ...
Germany's CureVac and Britain's GSK have settled a years-long patent dispute with Pfizer and its partner BioNTech over the ...
This week, President Donald Trump called Operation Warp Speed, a public-private federal program that helped speed up the ...
16hon MSN
GSK, CureVac to receive $740M as COVID vaccine patent dispute with Pfizer, BioNTech settled
CureVac (CVAC) and GSK (GSK) to receive $740M and other payments in a settlement with Pfizer (PFE) and BioNTech (BNTX) over ...
HHS Secretary Kennedy’s decision is based on a fundamental misunderstanding of vaccinology that could cost lives in future pandemics.
The federal government’s decision to slash $500 million in funding for mRNA vaccine research has sparked concern among health ...
The chapter on Pfizer and BioNTech’s mRNA patent feud with Germany’s CureVac is coming to a close, even as lawsuits over the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results